Molecularinstruments
Los Angeles, US · 1 known investors
Find your way into Molecularinstruments
Molecular Instruments develops HCR (hybridization chain reaction) imaging products for enzyme-free, multiplex, quantitative in situ hybridization and immunofluorescence, enabling detection of RNA and protein targets. Its products serve researchers in life sciences performing high-resolution imaging and expression profiling of cells and tissue samples.
Founders & leadership
DH
Dr. Harry M.T. ChoiFounder & CEO
PN
Prof. Niles A. PierceFounder & Chair of the Board
Investors · 1
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Molecularinstruments do?
- Molecular Instruments develops HCR (hybridization chain reaction) imaging products for enzyme-free, multiplex, quantitative in situ hybridization and immunofluorescence, enabling detection of RNA and protein targets. Its products serve researchers in life sciences performing high-resolution imaging and expression profiling of cells and tissue samples.
- Who founded Molecularinstruments?
- Molecularinstruments was founded by Dr. Harry M.T. Choi, Prof. Niles A. Pierce.
- Who are Molecularinstruments's investors?
- Molecularinstruments's investors include FREEFLOW.
- Where is Molecularinstruments headquartered?
- Molecularinstruments is headquartered in Los Angeles, US.